Rvnc shareholder alert: jakubowitz law reminds revance shareholders of a lead plaintiff deadline of february 8, 2022

New york, jan. 28, 2022 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of revance therapeutics, inc. (nasdaq: rvnc). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/revance-therapeutics-inc-loss-submission-form/?id=22663&from=4 the lawsuit seeks to recover losses for shareholders who purchased revance between november 25, 2019 and october 11, 2021.
RVNC Ratings Summary
RVNC Quant Ranking